D
DermaSensor
Health technology company designing tools to better equip primary care providers for skin cancer checks
About DermaSensor
DermaSensor is a health technology company that has developed a handheld device for the early detection of skin cancer. The device is designed to be used by primary care physicians, enabling them to conduct non-invasive assessments of skin lesions during routine check-ups.
The core technology combines optical spectroscopy and artificial intelligence. By analyzing the light reflected from a skin lesion, the device's proprietary algorithms can assess the risk of cancer in real-time. This provides immediate results to the physician, helping them to make more informed decisions about whether to refer a patient to a specialist for further investigation.
The company's business model is focused on selling these devices to healthcare providers, including individual physician offices, health systems, and walk-in clinics. By equipping primary care physicians with this tool, DermaSensor aims to improve the early detection rates of skin cancer, which can lead to better patient outcomes and lower healthcare costs.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- Miami, United States
- Employees
- 35
- Open positions
- None listed
- Dealroom signal
- 82.7/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Core AI, Spinout, AI Applications, DT and LS
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Oct 2025 | $16M | $64M | Kern Venture Group · Pier 70 Ventures · GenHenn Capital | ↗ |
| EARLY VCOther financing | Jun 2022 | $10M | $58M | Alberto Beeck · Maurice R. Ferre M.D. · Ernest Bachrach · Ceros capital Markets | ↗ |
Growth signals
Latest recorded traffic for DermaSensor is 30K monthly website visits, up 114.3% over the last three months. DermaSensor's team grew 12.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A9 investors entered at this stage
- DMDavid Matlin
SternAegis Ventures
Maurice R. Ferre M.D.
Alberto Beeck
Ernest Bachrach
Ceros capital Markets
Kern Venture Group
Pier 70 Ventures- GCGenHenn Capital
Other known investors1 additional known investor
Boston University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about DermaSensor on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See DermaSensor’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.